NEWS

Correction

In a story in the Feb. 2 News ("Gene Patent Race Speeds Ahead Amid Controversy, Concern," p. 184), a quotation was misattributed. The paragraph should read:

"Some people will feel that this is still not satisfactory public policy," Hanson (James Hanson, M.D., acting chief of the National Cancer Institute’s Clinical and Genetic Epidemiology Research Branch) acknowledged, "but it was the best we could do at this time," given Myriad’s intellectual property rights to the gene.



             
Copyright © 2000 Oxford University Press (unless otherwise stated)
Oxford University Press Privacy Policy and Legal Statement